Pricing Log in Create free account

BridgeBio Oncology Therapeutics, Inc (BBOT) vs Q32 Bio Inc. (QTTB)

BridgeBio Oncology Therapeutics, Inc and Q32 Bio Inc. are both Biotechnology companies. BridgeBio Oncology Therapeutics, Inc and Q32 Bio Inc. are of similar size ($236.5M and $231.3M). BridgeBio Oncology Therapeutics, Inc has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Across the 9 metrics below, Q32 Bio Inc. leads on 8 and BridgeBio Oncology Therapeutics, Inc on 1.

Valuation

Metric BBOT QTTB Biotechnology median
P/E n/m 2.49 8.50
P/S n/m n/m 9.71
P/B 0.70 1.44 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m (8.25) 9.21
Earnings yield (97.87%) 40.16% (33.15%)
Free cash flow yield (67.14%) (8.43%) (25.50%)

Profitability

Metric BBOT QTTB Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (252.10%) 72.14% (56.36%)
Return on assets (96.69%) 37.13% (48.04%)
Return on invested capital (127.66%) 0.00% 0.00%

Growth

Metric BBOT QTTB Biotechnology median
Revenue growth (TTM) — (307.33%) 6.02%
EPS growth (last fiscal year) 99.93% 148.96% 30.26%
Revenue growth, 5-year CAGR — 100.32% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BBOT QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.69 20.30 4.72
Net debt to EBITDA 2.93 (2.21) 0.96

Dividend

Metric BBOT QTTB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BBOT QTTB Biotechnology median
Market cap 236.52m 231.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack